166 related articles for article (PubMed ID: 8453721)
21. Molecular pathogenesis of transplacentally induced mouse lung tumors.
Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
[TBL] [Abstract][Full Text] [Related]
22. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia.
Sunday ME; Willett CG; Patidar K; Graham SA
Lab Invest; 1994 Jun; 70(6):875-88. PubMed ID: 8015292
[TBL] [Abstract][Full Text] [Related]
23. Ki-ras activation in pancreatic carcinomas of Syrian hamsters induced by N-nitrosobis(2-hydroxypropyl)amine.
Ushijima T; Tsutsumi M; Sakai R; Ishizaka Y; Takaku F; Konishi Y; Takahashi M; Sugimura T; Nagao M
Jpn J Cancer Res; 1991 Sep; 82(9):965-8. PubMed ID: 1657847
[TBL] [Abstract][Full Text] [Related]
24. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
25. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
26. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors.
Nickell-Brady C; Hahn FF; Finch GL; Belinsky SA
Carcinogenesis; 1994 Feb; 15(2):257-62. PubMed ID: 7545909
[TBL] [Abstract][Full Text] [Related]
27. Frequent mutations of Ki-ras codon 12 in N-bis (2-hydroxypropyl)-nitrosamine-initiated thyroid, kidney and lung tumors in Wistar rats.
Kitahori Y; Naito H; Konishi N; Ohnishi T; Shirai T; Hiasa Y
Cancer Lett; 1995 Sep; 96(2):155-61. PubMed ID: 7585451
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
29. Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice.
Hisamoto A; Kondo E; Kiura K; Okada T; Hosokawa S; Mimoto J; Takigawa N; Tabata M; Tanimoto M
Lung Cancer; 2007 Oct; 58(1):15-20. PubMed ID: 17604873
[TBL] [Abstract][Full Text] [Related]
30. K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation.
Keohavong P; Kahkonen B; Kinchington E; Yin J; Jin J; Liu X; Siegfried JM; DI YP
Anticancer Res; 2011 Sep; 31(9):2877-82. PubMed ID: 21868532
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
32. Induction of respiratory tract tumors in Syrian golden hamsters by a single dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and the effect of smoke inhalation.
Hecht SS; Adams JD; Numoto S; Hoffmann D
Carcinogenesis; 1983 Oct; 4(10):1287-90. PubMed ID: 6616756
[TBL] [Abstract][Full Text] [Related]
33. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
34. Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells.
Tiano HF; Wang RL; Hosokawa M; Crespi C; Tindall KR; Langenbach R
Carcinogenesis; 1994 Dec; 15(12):2859-66. PubMed ID: 8001247
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12.
Fujii H; Egami H; Chaney W; Pour P; Pelling J
Mol Carcinog; 1990; 3(5):296-301. PubMed ID: 2173932
[TBL] [Abstract][Full Text] [Related]
36. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
[TBL] [Abstract][Full Text] [Related]
37. Placental transfer of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone instilled intratracheally in Syrian golden hamsters.
Jorquera R; Castonguay A; Schuller HM
Cancer Res; 1992 Jun; 52(12):3273-80. PubMed ID: 1596885
[TBL] [Abstract][Full Text] [Related]
38. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
39. Lack of correlation between DNA methylation and hepatocarcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Liu L; Castonguay A; Gerson SL
Carcinogenesis; 1992 Nov; 13(11):2137-40. PubMed ID: 1423885
[TBL] [Abstract][Full Text] [Related]
40. K-ras mutations are frequent in pulmonary squamous cell carcinomas but not in adenocarcinomas of WBN/Kob rats induced by N-nitrosobis(2-oxopropyl)amine.
Ohgaki H; Furukawa F; Takahashi M; Kleihues P
Carcinogenesis; 1993 Jul; 14(7):1471-3. PubMed ID: 8330367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]